NorthWest Biotherapeutics Inc (NWBO)

[Stillwell888]

The PIM designation was granted in Sept. 2014 but apart from building out the Sawston facility until the NICE application was there was no further news on the U.K. regulatory front. We even know that U.K. patients were forced to go to the U.S. to get the vaccine made (see Kat's Cure). So my guess is the company decided to forgo the EAMS. They were/are in no position to give away the treatment for free. I believe there are about 2,000 newly diagnosed GBM patients per year in the U.K. If they made DCVax-L available under EAMS who would they decided to treat? Wouldn't it be unethical to offer it on a limited basis? If so then the NICE application is a precursor to full approval and not EAMS.